ABSTRACT Foxc2, a member of the winged helix transcription factor family, is essential for eye, calvarial bone, cardiovascular and kidney development in mice. Nevertheless, how Foxc2-expressing cells and their descendent cells contribute to the development of these tissues and organs has not been elucidated. Here, we generated a Foxc2 knock-in (Foxc2 ; R26R), the fate of Foxc2 positive (Foxc2 + ) cells was analyzed through LacZ staining at various embryonic stages. We found Foxc2 + cell descendants in the supraoccipital and exoccipital bone in E18.5 embryos, when tamoxifen was administered at embryonic day (E) 8.5. Furthermore, Foxc2 + descendant cranial neural crest cells at E8-10 were restricted to the corneal mesenchyme, while Foxc2 + cell derived cardiac neural crest cells at E6-12 were found in the aorta, pulmonary trunk and valves, and endocardial cushions. Foxc2 + cell descendant contributions to the glomerular podocytes in the kidney were also observed following E6.5 tamoxifen treatment. Our results are consistent with previous reports of Foxc2 expression during early embryogenesis and the Foxc2
INTRODUCTION
Foxc2 (MFH-1) is a member of the winged helix/forkhead family of proteins. Foxc2 loss-of-function mice exhibit many developmental malformations including perturbed corneal neovascularization, eye defects, cleft palate, ventricular septum defect (VSD) of the heart, abnormal myocardium, and small kidneys with cystic glomeruli and aberrant proximal tubules (Kume et al. 2000 , Bahuau et al. 2002 , Sasman et al. 2012 , Motojima et al. 2016 . Many reports also indicate that Foxc2 loss-of-function causes pre-and peri-natal death in association with skeletal, genitourinary tract, and cardiovascular defects (Iida et al. 1997 , Winnier et al. 1997 , 1999 , Kume et al. 2000 , Kanzaki-Kato et al. 2005 , Seo and Kume 2006 . Collectively, these studies indicate that Foxc2 is a key regulator of calvaria bone, eye, heart and kidney development, and in further support of this idea, similar abnormalities have been found in individuals with FOXC2 mutations (Fang et al. 2000 , Mellor et al. 2007 , Rasouly and Lu 2013 .
The constellation of defects in the aforementioned organs is thought to arise from cell autonomous Foxc2 loss-of-function (Uddin et al. 2015 , Motojima et al. 2016 . Therefore, we hypothesized that the cell-type specific phenotypes observed in Foxc2 mutants is directly related to the expression of Foxc2 in the respective tissues and organs. Analysis of the temporal and cell type-specific expression of Foxc2 can therefore provide a clear picture concerning the distinct spatiotemporal role of Foxc2 in progenitor and descendent populations. Although previous reports have characterized the expression of Foxc2 mRNA via in situ hybridization (Miura et al. 1993 , Winnier et al. 1997 , Hiemisch et al. 1998 ), a detailed cell type-specific analysis of Foxc2 expression and the contribution of Foxc2 + daughter cells during embryonic morphogenesis remains to be performed. Therefore, we established a new mouse model for indelibly labeling Foxc2
+ cells at precise stages during embryonic development. This genetic tracing approach involves activation of a modified form of Cre recombinase (CreERT2) following administration of a chemical ligand tamoxifen (Tam) to monitor Foxc2 + cells by β-galactosidase (β-gal) reporter gene expression using R26R mice (Soriano 1999) .
It is known that the development of cartilage and connective tissue of the head, eye mesenchyme, and heart is greatly influenced by cephalic neural crest cells (NCCs) (Clouthier et al. 1998) . Furthermore, cardiac neural crest cells (CNCCs) play crucial roles in morphogenesis and patterning of the developing heart (Kirby 1993, Kirby and Waldo 1995) . The formation, migration, proliferation and lineage determination or differentiation fate of NCCs are guided by multiple transcription factors (Anderson 1997) . Therefore, we compared the distribution of Foxc2 + cell descendants at various developmental stages after tamoxifen administration, with the pattern of NCC contribution in the eye and cardiac regions.
MATERIALS AND METHODS
Generation of the Foxc2 conditional knock-in mouse strain A genomic DNA fragment of Foxc2 gene was isolated from a 129/SvJ mouse genomic library (Stratagene, CA, USA). To generate Foxc2 CreERT2 alleles, a CreERT2 cassette was inserted downstream of the initiation codon of Foxc2, followed by an Frtflanked PGK-Neo R sequence in targeted embryonic stem (ES) cells. Neo R allows for positive selection of cells containing an integrated copy of the targeting vector using G418 (Sigma-Aldrich, St. Louis, MO, USA). Diphtheria toxin A (DTA) and thymidine kinase (TK) under the control of the MC1 promoter were inserted flanking the 5′ and 3′ untranslated regions, respectively, allowing selection against unwanted random integration (Uddin et al. 2015) . The targeting vector was electroporated into the ES cells. Only G418 and gancyclovir (Sigma-Aldrich)-resistant ES cell colonies were isolated and subjected to Southern blot analysis using a 5′ probe that hybridized upstream of the 5′ short arm of DNA from the ES clone after enzymatic digestion (HindIII). The desired clones were then injected into host blastocysts to produce germline chimeras as described previously (Tanaka et al. 1995) .
Foxc2
CreERT2-Neo chimeric mice were crossed with Act-FLPe mice to remove the PGK-Neo cassette, generating two Foxc2
CreERTT2/+ mice line (Uddin et al. 2015) .
Mouse and embryo genotyping Foxc2
CreERT2 mice were crossed with ROSA-LacZ reporter (R26R) mice to obtain embryos (Soriano 1999) . Embryonic day (E) was defined as 0.5 at 12 pm on the day the vaginal plug was identified. The Cre (100 bp) and polymerase chain reaction (PCR) control (320 bp) specific primer sequences respectively used for genotyping by PCR were: 5′-GCGGTGTGGCAGTAAAAACTATC-3′ 5′-GTGAAACAGCATTGCTGTCACTT-3′ 5′-CTAGGCCACAGAATTGAAAGATCT-3′ 5′-GTAGGTAATTCTAGCATCATCC-3′.
Tamoxifen injection
Tamoxifen was dissolved in corn oil as a stock solution (20 mg/mL; Sigma-Aldrich). Each pregnant dam received an intraperitoneal injection of 2 mg/25 g body weight (Wu et al. 2014) of tamoxifen between E6.5 and E12.5 stages of embryogenesis.
X-gal staining
Whole-mount and section X-gal staining was performed as previously described (Yoshida et al. 2008 , Uddin et al. 2015 with some modification. Briefly, dissected embryos were fixed in a glutaraldehyde/formalin solution at 4°C for various times depending on age (E7-10, 30 min; E11-14, 1-2 h), washed with phosphatebuffered saline (PBS), and whole-mount stained using X-gal (Takara Biochemicals, Japan) solution (1 mg/mL X-gal, 2 mM MgCl 2 , 0.02% NP-40, 0.01% sodium deoxycholate, 5 mM potassium ferricyanide and 5 mM potassium ferrocyanide). For cryosection staining, following fixation, the embryos were sequentially processed through graded sucrose/PBS solutions (5%, 10%, 15%, and 20%) before being embedded in sucrose/OCT compound (Tissue-Tek, Japan). The 10 μm embryo sections were re-fixed in 4% formalin, stained with X-gal solution, washed with PBS, dehydrated in an Desired insertion was confirmed by Southern blot analysis using a 5′ probe that hybridized upstream of the 5′ short arm of digested (HindIII) DNA from ES cells. Southern blot shows duplicate samples of heterozygous and wild-type bands. 5′ probe-detected 9.1 kb and 4.0 kb fragments were derived from wildtype and knock-in alleles, respectively after HindIII digestion. (C) PCR genotyping to confirm the knock-in allele gene in tamoxifeninducible mice. The 100 bp fragment was detected by primers (P3 and P4) for the knock-in allele. DTA, diphtheria toxin A; TK, thymidine kinase.
Foxc2
CreERT2 knock-in mice 25 ethanol/xylene series, and mounted in Mount-Quick medium (Daido Sangyo Co., Japan). Images were captured using an Olympus DP72 digital camera and Olympus BX-51 microscope.
Immunohistochemistry
The immunostaining for β-gal (1:2000, Capple, CA, USA), Foxc2 antibody (Uddin et al. 2015) (1: 1000) and neural crest marker, Ap2α (1:50, Iowa hybridoma, Iowa, USA) was performed as described previously (Aoto et al. 2015) .
RESULTS

Generation of the Foxc2
CreERT2 mouse strain To indelibly label and follow the fate of Foxc2 + cells and their daughter cells during embryogenesis, we used the Tam-inducible CreERT2/loxP recombination system (Indra et al. 1999) . For this purpose, a CreERT2 transgene was inserted downstream of the Foxc2 initiation codon by homologous recombination (Fig. 1A) . The resulting vector was electroporated into mouse ES cells. Five clones containing Foxc2
CreERT2 alleles were screened from 480 ES clones (data not shown) by Southern blot analysis. A 5′-probe detected 9.1 kb and 4.0 kb fragments representing the wild-type and knock-in alleles, respectively, after HindIII digestion (Fig. 1B) . The presence of CreERT2 in the knock-in allele was confirmed using PCR in which a 100 bp band size indicated Cre-positive mice (Fig. 1C) .
Establishment of the Foxc2
CreERT2 ; R26R mice line for lineage tracing analysis To evaluate whether the Foxc2
CreERT2 allele functions as expected, Foxc2
CreERT2 mice were crossed with the ROSA (R26R) reporter line (Soriano 1999 ) to monitor CreERT2 activity by β-gal expression in Foxc2 + cells at various developmental time points. Once Tam is injected intraperitoneally into mice, cytoplasmic CreERT2 protein translocates into the nucleus where it carries out site-specific recombination between flanking loxP sites (Lepper and Fan 2012) . We confirmed no lacZ labeling prior to Tam exposure (data not shown).
During late gastrulation stages of mouse development, E6.5➔7.5 (Tam injection at E6.5 and embryo isolation at E7.5), Foxc2 was first identified in the nascent mesoderm ( Fig. 2A ), but no expression was found in axial mesoderm (data not shown). In E7.5➔8.5 embryos with 7 and 15 somites, Foxc2 was detected in the newly formed somites, heart primordium, and cephalic and presomitic mesoderm (Fig. 2B, C) . Subsequently, in E8.5➔9.5 and E9.5➔10.5 embryos, Foxc2 expression in the presomitic mesodermal region and heart area become more prominent, while somites in the rostral part and cephalic mesoderm showed a decreased Foxc2 + population following their differentiation. At these stages, Foxc2 was expressed in the proximal part of pharyngeal arches and mesenchymal condensation surrounding developing eyes (Fig. 2D, E) . In E10.5➔11.5 and E11.5➔12.5 embryos, Foxc2 expression was observed in the tail, forelimb, hindlimb, blood vessels, and mesenchymal condensation of vertebrae along with the eye mesenchyme and optic vesicle (Fig. 2F, G) . In later embryos (E12.5➔13.5 and E13.5➔14.5), Foxc2 was expressed in digits, elbow and knee joints (Fig. 2H, I ), and tail bud (data not shown). These data indicate that Foxc2 is dynamically expressed and that descendants of Foxc2 + cells as evidenced by β-gal-labeling contribute extensively throughout the embryo.
E8 mesodermal Foxc2
+ cells contribute to supraoccipital and exoccipital bones Next, we examined the contribution of Foxc2 + lineage cells to the developing skeletal elements of the head to clarify their relationship with the skull phenotypes reported in Foxc2 mutant mice (Winnier et al. 1997) . After Tam injection at E8.5, whole skull lacZ staining together with alizarin red counterstaining marked Foxc2 + cell descendants in the supraoccipital bone and between parietal and interparietal bones at E18.5 (Fig. 3A, B , white arrow). Foxc2 + lineage traced cells also contributed to the corneal mesenchyme, exoccipital bone, otic capsule, and mesenchyme surrounding the eye (Fig. 3C, D) . In contrast, Tam exposure at E10.5 showed no β-gal + cells specifically in supraoccipital or exoccipital bones (data not shown), White arrows, developing eye staining; (F-H) black arrowheads, β-gal staining at forelimb and hindlimb muscles; (I) white arrowheads, staining of forelimb and hindlimb digits. CM, cephalic mesoderm; H, heart primordium; OV, optic vesicle; P, presomitic mesoderm; pa, pharyngeal arches; so, somite; T, tail bud. Scale bar, 50 μm.
in agreement with the results in Figure 2 . Furthermore, other bones such as nasal and frontal bones were always negative for descendants of Foxc2 + cells (Fig. 3) .
Overlapping of Foxc2 + cells with NCCs in the ocular region We also determined the precise location of Foxc2 + cell descendants in a chronological order inside the eye region. Each pregnant mouse received a single injection of Tam at one of four defined time points (E6.5, E8.5, E10.5 and E12.5) and embryos were isolated at E14.5 and stained with X-gal. Tam exposure at E6.5 followed by β-gal staining revealed few Foxc2 + cell descendants in the periocular mesenchyme, corneal mesenchyme, mesenchyme surrounding the optic nerve, cartilage primordium of nasal septum and lingual muscles (Fig. 4A, unpublished data) . Tam exposure at E8.5 and E10.5 revealed an increased number of Foxc2 + cell descendants in these regions except for the lingual muscle layer in E10.5➔14.5 embryos (Fig. 4B, C) . At a later Tam injection point (E12.5), Foxc2 + lineage traced cells were restricted to the corneal mesenchyme (Fig. 4D) . These results suggest that the descendants of mesenchymal Foxc2 + cells undergo continuous division and proliferation to generate the descendent cells in the extraocular muscles from E6.5 to E10.5 Tam injection and finally restricted to corneal mesenchyme during ocular development.
Fate mapping analysis of NCCs to the ocular primordia reported the contribution of Foxc2 + NCCs in the periocular mesenchyme (Gage et al. 2005) (Fig. 4E) . Antibody staining for Foxc2 in combination with the NCC marker AP2α revealed co-staining in the periocular mesenchyme (Fig. 4F-I ). The comparisons implied a similar pattern of Foxc2 + cell descendants and NCCs in the periocular mesenchyme and corneal mesenchyme as revealed by a previous report (Gage et al. 2005 ).
Foxc2
+ migrating CNCCs in the outflow tract and atrioventricular cushion The important roles of Foxc2 in cardiac patterning and morphogenesis have been elucidated by single knockout and/or 
CreERT2 knock-in mice 27 combinatorial mutants with a closely related forkhead transcription factor, Foxc1 (Iida et al. 1997 , Winnier et al. 1999 , Kume et al. 2001 , Kanzaki-Kato et al. 2005 . Descendants of Foxc2 + cells labeled at E6.5 were found in mesenchyme of the aorta and pulmonary trunk and valves, endothelial lining of the atria, endocardium, and some portions of atrioventricular (AV) endocardial cushions at E14.5 (Fig. 5A, E, I , M). The extent of contribution was enhanced in the aforementioned regions following Tam administration at E8.5 (Fig. 5B,  F, J, N) . Foxc2 + cell descendants were asymmetrically restricted to the endothelial lining of the aorta (Fig. 5P) , the pulmonary valve (Fig. 5O), and trunk (Fig. 5H ) between E10.5 and E12.5. In contrast, contribution to the endocardium was reduced (Fig. 5K, L) . These data demonstrated that Foxc2 + progenitor cells provide a considerable source of endothelial and mesenchymal cells during cardiac morphogenesis.
Similar to our comparative analyses of Foxc2 + cell descendants and NCCs in the ocular region, we also used Wnt1 Cre ; R26R mice to determine the comparative contribution of Foxc2 + cell descendant NCC in cardiac tissue (Fig. 5Q-T) . CNCCs contribute to multiple components of cardiac development (Brown et al. 2001) . In Wnt1
Cre/+ ; R26R
Lacz/+ embryos, the expression of β-gal in the endothelium of aorta, pulmonary trunk, and particularly in the portion of AV cushion tissue resembled that of fatemapped Foxc2 + cell descendants ( Fig. 5A -P, Q-T). This suggested that a considerable number of Foxc2 + cell descendants were also of NCC origin. In agreement with this observation, the expression of Foxc2 in E10.5 embryos overlapped with the expression of a classic NCC marker Ap2α, and β-gal labeled NCCs in portions of outflow tract (OFT) (Fig. 6A-G) . The overlapping patterns suggest that Foxc2 + migrating NCCs might be specifically required for OFT septation and/or AV cushionderived membranous septum formation, defects in which were reported in Foxc2 À/À mutant mouse embryos (Eisenberg and Markwald 1995) .
Spatial expression pattern of Foxc2 in the nephrogenic zone during kidney formation Foxc2 coupled with Foxc1 acts as a transcriptional regulator of intermediate mesoderm-derived cell fate that ultimately gives rise to kidney precursors (Kume et al. 2000) . Tissue-specific deletion of Foxc2 using a kidney-specific Pax2-Cre mice causes perinatal death in association with to cystic glomeruli and a reduced number of proximal tubules (Motojima et al. 2016) . Therefore, fate mapping of Foxc2 + cell descendants and their temporal contributions is required to understand the function of Foxc2 in relation to kidney development and congenital anomalies. Here, kidneys at E18.5 were examined following Tam administration at E6.5, E8.5, E10.5, E12.5, and E14.5. Foxc2 + cell descendants were first observed in comma-shaped nephrons and a few medullary stromal cells. No apparent renal (cortex and medulla) tubular cells were positive for Foxc2 + cell descendants following Tam injection at E6.5 (Fig. 7B, C) . Tam administration at E8.5 revealed Foxc2 + cell descendants in S-shaped nephrons with an increased contribution to renal stromal cells (Fig. 7E, F) . Injection of Tam at E10.5 directed Foxc2 + cell descendants in capillary loopstage nephrons with increased proximal and distal tubular cell contribution (Fig. 7H, I ). In contrast, Tam injection at E12.5 illustrated the contribution of Foxc2 + cell descendants to mature renal corpuscles with a concomitant decrease in stromal and tubular populations (Fig. 7K, L) . Tam at E14.5 demarcated Foxc2
+ cell descendants only in mature renal corpuscles of stage IV nephrons, as no β-gal-labeled cells were found in the renal stroma ( Fig. 7N and O). These data indicate that Foxc2 + cell descendant nephrogenic progenitor cells required to maintain glomerular morphogenesis are generated during early embryogenesis. ' 
DISCUSSION
We have successfully demonstrated Foxc2 + cell descendants contribute to some of the cephalic mesoderm-derived calvarial bones Tam exposure at E8.5-10.5 revealed Foxc2 + cell descendants restricted to the mesenchyme surrounding periocular regions (Fig. 4) .
Foxc2
+ cell descendants in the periocular mesoderm may provide the corneal mesenchyme and the trabecular meshwork for proper ocular and anterior segment development (Fuhrmann et al. 2000 , Finegold et al. 2001 ). Wnt1
Cre ; R26R and αGsu-Cre; R26R mice have previously revealed NCC contributions to the periocular mesenchyme (Gage et al. 2005) . However, in contrast to Wnt1 Cre ; R26R mice, Foxc2 + cell descendants were not found only in the corneal mesenchyme at E12.5 (Fig. 4) . Foxc2 + cell descendent were evidently committed to the OFTderived aorta, pulmonary trunk and valves, and endocardial cushion of AV regions at early stages (E6.5-10.5). At E12.5, the contribution was asymmetrically limited to the endothelial lining of aorta, pulmonary trunk and valve (Fig. 5 H, arrow) . These results are similar to the expression pattern of Foxc2 mRNA in the OFT and AV cushion regions (Gitler et al. 2003) . In addition, similar to the Foxc2 lineage tracing, Foxc2 immunostaining and Wnt1
Cre ; R26R lineage tracing were indicative of CNCC contributions to the OFT and AV cushions ( Fig. 5Q-T, Fig. 6 ). Thus, the overlapping patterns indicated that Foxc2 + CNCCs or Foxc2 + cell descendant CNCCs might play an important role in OFT septation and/or ventricular septum formation. Our unpublished data also support that the demonstration that NCCspecific Foxc2 conditional knockout results in ventricular septal defect (VSD) of the heart. However, a detailed investigation of the spatiotemporal requirement for Foxc2 is required in conditional knock-out mice to clarify the exact role of Foxc2 in CNCCs during cardiac morphogenesis.
Our study however links Foxc2-expression pattern at various stages of embryonic development and the subsequent contribution of Foxc2 + cell descendants to the Foxc2 mutant phenotype, which includes craniofacial, heart, and kidney defects. Our newly established Foxc2
CreERT2 inducible genetic lineage tracing mouse model provides the foundation for demonstrating the stagespecific requirement and functions of Foxc2 during murine embryogenesis.
